Carisma Therapeutics Stock Probability of Future Stock Price Finishing Over 1.7
| CARM Stock | 1.35 0.09 7.14% |
Carisma |
Carisma Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Carisma Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Carisma Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Carisma Therapeutics generated a negative expected return over the last 90 days | |
| Carisma Therapeutics may become a speculative penny stock | |
| Carisma Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 14.92 M. Net Loss for the year was (86.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Carisma Therapeutics generates negative cash flow from operations | |
| Carisma Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 29.0% of the company shares are held by company insiders |
Carisma Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Carisma Stock often depends not only on the future outlook of the current and potential Carisma Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Carisma Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.5 M | |
| Cash And Short Term Investments | 77.6 M |
Carisma Therapeutics Technical Analysis
Carisma Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Carisma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Carisma Therapeutics. In general, you should focus on analyzing Carisma Stock price patterns and their correlations with different microeconomic environments and drivers.
Carisma Therapeutics Predictive Forecast Models
Carisma Therapeutics' time-series forecasting models is one of many Carisma Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Carisma Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Carisma Therapeutics
Checking the ongoing alerts about Carisma Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Carisma Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Carisma Therapeutics generated a negative expected return over the last 90 days | |
| Carisma Therapeutics may become a speculative penny stock | |
| Carisma Therapeutics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 14.92 M. Net Loss for the year was (86.88 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Carisma Therapeutics generates negative cash flow from operations | |
| Carisma Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 29.0% of the company shares are held by company insiders |
Check out Carisma Therapeutics Backtesting, Carisma Therapeutics Valuation, Carisma Therapeutics Correlation, Carisma Therapeutics Hype Analysis, Carisma Therapeutics Volatility, Carisma Therapeutics History as well as Carisma Therapeutics Performance. To learn how to invest in Carisma Stock, please use our How to Invest in Carisma Therapeutics guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Carisma Stock analysis
When running Carisma Therapeutics' price analysis, check to measure Carisma Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carisma Therapeutics is operating at the current time. Most of Carisma Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carisma Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carisma Therapeutics' price. Additionally, you may evaluate how the addition of Carisma Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Carisma Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Carisma Therapeutics. If investors know Carisma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Carisma Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Carisma Therapeutics is measured differently than its book value, which is the value of Carisma that is recorded on the company's balance sheet. Investors also form their own opinion of Carisma Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Carisma Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Carisma Therapeutics' market value can be influenced by many factors that don't directly affect Carisma Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Carisma Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Carisma Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Carisma Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.